ZA200810528B - Procedure and methods for detecting Alzheimer's disease - Google Patents

Procedure and methods for detecting Alzheimer's disease

Info

Publication number
ZA200810528B
ZA200810528B ZA200810528A ZA200810528A ZA200810528B ZA 200810528 B ZA200810528 B ZA 200810528B ZA 200810528 A ZA200810528 A ZA 200810528A ZA 200810528 A ZA200810528 A ZA 200810528A ZA 200810528 B ZA200810528 B ZA 200810528B
Authority
ZA
South Africa
Prior art keywords
disease
procedure
methods
detecting alzheimer
alzheimer
Prior art date
Application number
ZA200810528A
Other languages
English (en)
Inventor
Schweighoffer Fabien
Bracco Laurent
Original Assignee
Exonhit Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exonhit Therapeutics Sa filed Critical Exonhit Therapeutics Sa
Publication of ZA200810528B publication Critical patent/ZA200810528B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200810528A 2006-05-15 2008-12-11 Procedure and methods for detecting Alzheimer's disease ZA200810528B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0604294A FR2900936B1 (fr) 2006-05-15 2006-05-15 Procede et methodes de detection de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
ZA200810528B true ZA200810528B (en) 2009-10-28

Family

ID=37496633

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200810528A ZA200810528B (en) 2006-05-15 2008-12-11 Procedure and methods for detecting Alzheimer's disease

Country Status (12)

Country Link
US (1) US20100055682A1 (xx)
EP (1) EP2021509A2 (xx)
JP (1) JP2009537133A (xx)
KR (1) KR20090098941A (xx)
CN (1) CN101490280B (xx)
AU (1) AU2007251408B2 (xx)
CA (1) CA2652258A1 (xx)
FR (2) FR2900936B1 (xx)
IL (1) IL195288A (xx)
NZ (1) NZ573505A (xx)
WO (1) WO2007132120A2 (xx)
ZA (1) ZA200810528B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2929292A1 (fr) 2008-03-28 2009-10-02 Exonhit Therapeutics S A Sa Procede et methodes de diagnostic de la maladie d'alzheimer
ES2628944T3 (es) * 2008-05-23 2017-08-04 Mochida Pharmaceutical Co., Ltd. Método para la evaluación de la función de fagocitos
US20100099609A1 (en) * 2008-07-28 2010-04-22 Buck Institute For Age Research eAPP AND DERIVATIVES FOR TREATMENT OF ALZHEIMER'S DISEASE
KR101295019B1 (ko) * 2011-04-22 2013-08-09 경북대학교 산학협력단 리포칼린 2 수준을 측정하는 것을 포함하는 경도 인지 장애 진단용 조성물, 키트 및 경도인지 장애 진단을 위한 정보 제공방법.
US9541561B2 (en) 2012-06-14 2017-01-10 Electronics And Telecommunications Research Institute Method for diagnosing Alzheimer's disease using biomaterial
EP2728015A1 (en) * 2012-10-31 2014-05-07 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for the Sezary's Syndrome diagnosis
WO2016024101A1 (en) * 2014-08-13 2016-02-18 Timmons James Archibald Healthcare diagnostic
CN104328200B (zh) * 2014-11-18 2016-04-06 宁波大学 辅助诊断阿尔茨海默病的检测试剂盒及其检测方法
WO2019049705A1 (ja) * 2017-09-08 2019-03-14 自然免疫制御技術研究組合 アルツハイマー症診断装置及び方法
WO2023005959A1 (en) * 2021-07-27 2023-02-02 The Hong Kong University Of Science And Technology Compositions and methods for treating alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791660A1 (en) * 1996-02-22 1997-08-27 Smithkline Beecham Corporation A novel diagnostic marker for splicing variants of genes associated with neurological function
EP1303537B1 (en) * 2000-07-25 2006-09-27 The Sir Mortimer B. Davis-Jewish General Hospital Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases
DE60312656T2 (de) * 2002-01-31 2007-11-29 Daiichi Pharmaceutical Co., Ltd. Arzneimittel zur behandlung von störungen des zirkadianen rhythmus
US20050065082A1 (en) * 2002-03-29 2005-03-24 Hirofumi Doi C-jun phosphorylation inhibitors
US7250496B2 (en) * 2002-11-14 2007-07-31 Rosetta Genomics Ltd. Bioinformatically detectable group of novel regulatory genes and uses thereof
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method

Also Published As

Publication number Publication date
FR2980484A1 (fr) 2013-03-29
US20100055682A1 (en) 2010-03-04
CN101490280A (zh) 2009-07-22
AU2007251408B2 (en) 2012-11-29
EP2021509A2 (fr) 2009-02-11
KR20090098941A (ko) 2009-09-18
WO2007132120A3 (fr) 2008-05-08
JP2009537133A (ja) 2009-10-29
FR2900936A1 (fr) 2007-11-16
CA2652258A1 (fr) 2007-11-22
NZ573505A (en) 2011-04-29
FR2900936B1 (fr) 2013-01-04
CN101490280B (zh) 2012-09-26
WO2007132120A2 (fr) 2007-11-22
AU2007251408A1 (en) 2007-11-22
IL195288A (en) 2013-10-31
IL195288A0 (en) 2009-08-03

Similar Documents

Publication Publication Date Title
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
IL211540A0 (en) Optical method for the detection of alzheimer's disease
SI2324126T1 (sl) Postopek identifikacije dejavnikov tveganja za Alzheimerjevo bolezen
IL188165A0 (en) Method for the diagnosis of alzheimer's disease
BRPI0715287A2 (pt) "método de avaliação do progresso de cicatrização de feridas"
EP2091566A4 (en) COMBINATION THERAPIES AGAINST ALZHEIMER DISEASE AND SIMILAR ILLNESSES
DE602006009764D1 (de) Terphenylderivate zur Alzheimerbehandlung
EP2011513A4 (en) THERAPEUTIC AGENTS AGAINST ALZHEIMER DISEASE AND CANCER
EP2018163A4 (en) ILLUSTRATIVE APPARATUS AND METHOD
EP2198292A4 (en) BETTER DIAGNOSIS OF ALZHEIMER'S DISEASE
EP2046396A4 (en) METHOD AND MEANS FOR PRODUCING 18F RAY-MARKED FLUORINATING AGENTS
EP1877416A4 (en) SAPOSIN D AND FAM3C ARE BIOLOGICAL MARKERS FOR ALZHEIMER DISEASE
EP2231180A4 (en) VACCINE AGAINST ALZHEIMER'S DISEASE
GB0616919D0 (en) Cyclist's Aid
EP2375895A4 (en) METHOD OF TREATING ALZHEIMER'S DISEASE AND RELATED STATES
EP2344881A4 (en) BIOMARKER FOR MORBUS ALZHEIMER
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1909836A4 (en) METHODS OF TREATING AND DETECTING BETA CELL ASSOCIATED DISEASE
EP2147117A4 (en) METHOD FOR DIAGNOSIS OF MORBUS ALZHEIMER AND MARKERS IDENTIFIED BY SET ASSOCIATION
EP2305629A4 (en) THERAPEUTIC AGENT FOR ALZHEIMER'S DISEASE
EP1832877A4 (en) METHOD FOR THE STUDY OF MORBUS ALZHEIMER
EP2099476A4 (en) METHODS OF TREATING ALZHEIMER'S DISEASE
EP1863510A4 (en) METHOD FOR TREATING PARKINSON DISEASE
HUP0600409A3 (en) Izatin and it's derivatives for use as a medicine
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease